{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:38:08Z","timestamp":1788838688862,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 Parthenope di Napoli"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sudden cardiac death (SCD) remains a major cause of mortality among adults with congenital heart disease (ACHD). Risk stratification for malignant ventricular arrhythmias in this population is challenging because of the heterogeneity of anatomical substrates, lifelong haemodynamic changes, and the limited predictive accuracy of currently risk models. Furthermore, implantation of an implantable cardioverter-defibrillator (ICD) in ACHD patients is frequently complicated by anatomical constraints, limited venous access, and a significant burden of device-related complications, including infection involving prosthetic material. Several transient cardiac or systemic conditions\u2014including haemodynamic deterioration, acquired myocardial disease, infections, inflammatory states, pregnancy, endocrine disturbances, or peri-procedural phases\u2014may temporarily increase arrhythmic risk or impair ventricular function. In these scenarios, the indication for permanent ICD may be uncertain or premature. The wearable cardioverter-defibrillator (WCD) provides a non-invasive option for temporary protection against life-threatening ventricular arrhythmias while allowing time for clinical stabilization, diagnostic reassessment, and individualized decision-making. This review summarizes the pathophysiological rationale, available evidence, and potential clinical applications of WCD therapy in ACHD.<\/jats:p>","DOI":"10.1007\/s10741-026-10638-y","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:26:52Z","timestamp":1779690412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Wearable Cardioverter-Defibrillator in Adult Congenital Heart Disease: A Bridge to Decision, Recovery, and Advanced Therapies"],"prefix":"10.1007","volume":"31","author":[{"given":"Berardo","family":"Sarubbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Murredda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Domenico","family":"Ciriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Correra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Papaccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Colonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"10638_CR1","doi-asserted-by":"publisher","unstructured":"Khan A, Gurvitz M (2018) Sep-Oct;61(3\u20134):275\u2013281 Epidemiology of ACHD: What Has Changed and What is Changing? Prog Cardiovasc Dis. https:\/\/doi.org\/10.1016\/j.pcad.2018.08.004. Epub 2018 Aug 17. PMID: 30125582","DOI":"10.1016\/j.pcad.2018.08.004"},{"issue":"Suppl 1","key":"10638_CR2","doi-asserted-by":"publisher","first-page":"i25","DOI":"10.1093\/eurheartjsupp\/suaf090","volume":"28","author":"B Sarubbi","year":"2026","unstructured":"Sarubbi B, Waldmann V, Ciriello GD, Wong T, Cano \u00d3 (2026) Strategies for preventing arrhythmic sudden death in adult congenital heart disease. Eur Heart J Suppl 28(Suppl 1):i25\u2013i32. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suaf090","journal-title":"Eur Heart J Suppl"},{"issue":"40","key":"10638_CR3","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K de Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M, ESC Scientific Document Group (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43(40):3997\u20134126. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262","journal-title":"Eur Heart J"},{"issue":"11","key":"10638_CR4","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/europace\/eux380","volume":"20","author":"A Hern\u00e1ndez-Madrid","year":"2018","unstructured":"Hern\u00e1ndez-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Janousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K, ESC Scientific Document Group (2018) Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace 20(11):1719\u20131753. https:\/\/doi.org\/10.1093\/europace\/eux380","journal-title":"Europace"},{"issue":"16","key":"10638_CR5","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1161\/CIRCULATIONAHA.112.104786","volume":"126","author":"Z Koyak","year":"2012","unstructured":"Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, Budts W, Zwinderman AH, Van Gelder IC, Mulder BJ (2012) Sudden cardiac death in adult congenital heart disease. Circulation 126(16):1944\u20131954. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.104786","journal-title":"Circulation"},{"issue":"28","key":"10638_CR6","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1093\/eurheartj\/ehac288","volume":"43","author":"M Van De Ladouceur","year":"2022","unstructured":"Ladouceur M, Van De Bruaene A, Kauling R, Budts W, Roos-Hesselink J, Albert SV, Perez IS, Sarubbi B, Fusco F, Gallego P, Rodriguez-Puras MJ, Bouchardy J, Blanche C, Rutz T, Prokselj K, Labombarda F, Iserin L, Wong T, Gatzoulis MA (2022) A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle. Eur Heart J 43(28):2685\u20132694. https:\/\/doi.org\/10.1093\/eurheartj\/ehac288","journal-title":"Eur Heart J"},{"issue":"20","key":"10638_CR7","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/eurheartj\/ehaf137","volume":"46","author":"C Montanaro","year":"2025","unstructured":"Montanaro C, Arvanitaki A, Kerrigan W, Kadani Z, Barracano R, Scognamiglio G, Kempny A, Li W, Brida M, McDonnell E, Habibi H, Dimopoulos K, Rafiq I, Ee Ling H, Alam H, Sarubbi B, Diller GP, Gatzoulis MA (2025) The Fontan Adult Brompton clinical score and mortality risk. Eur Heart J 46(20):1933\u20131945. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf137","journal-title":"Eur Heart J"},{"issue":"6","key":"10638_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.14744\/AnatolJCardiol.2018.81782","volume":"19","author":"JT Vehmeijer","year":"2018","unstructured":"Vehmeijer JT, Mulder BJ, de Groot JR (2018) Current state of risk stratification for sudden cardiac death in adults with congenital heart disease. Anatol J Cardiol 19(6):401\u2013403. https:\/\/doi.org\/10.14744\/AnatolJCardiol.2018.81782","journal-title":"Anatol J Cardiol"},{"issue":"18","key":"10638_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/eurheartj\/ehv735","volume":"37","author":"JT Vehmeijer","year":"2016","unstructured":"Vehmeijer JT, Brouwer TF, Limpens J, Knops RE, Bouma BJ, Mulder BJ, de Groot JR (2016) Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis. Eur Heart J 37(18):1439\u20131448. https:\/\/doi.org\/10.1093\/eurheartj\/ehv735","journal-title":"Eur Heart J"},{"key":"10638_CR10","doi-asserted-by":"publisher","unstructured":"Sarubbi B, Correra A, Colonna D, Romeo E, Palma M, Merola A, D\u2019Alto M, Scognamiglio G, Fusco F, Barracano R, Borrelli N, Grimaldi N, D\u2019Onofrio A (2021) Russo M.G. Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD Monaldi Care registry. Int J Cardiol Cong Heart Dis Vol 3. https:\/\/doi.org\/10.1016\/j.ijcchd.2021.100091","DOI":"10.1016\/j.ijcchd.2021.100091"},{"issue":"6","key":"10638_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMoa1915932","volume":"383","author":"O van der KnopsRE","year":"2020","unstructured":"KnopsREO, Nordkamp LRA, Delnoy PHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, K\u00e4\u00e4b S, Mittal S, Quast ABE, Smeding L, van der Stuijt W, de Weger A, de Wilde KC, Bijsterveld NR, Richter S, Brouwer MA, de Groot JR, Kooiman KM, Lambiase PD, Neuzil P, Vernooy K, Alings M, Betts TR, Bracke FALE, Burke MC, de Jong JSSG, Wright DJ, Tijssen JGP, Wilde AAM (2020) PRAETORIAN Investigators. Subcutaneous or Transvenous Defibrillator Therapy. N Engl J Med 383(6):526\u2013536. https:\/\/doi.org\/10.1056\/NEJMoa1915932","journal-title":"N Engl J Med"},{"issue":"13","key":"10638_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","volume":"379","author":"JE Olgin","year":"2018","unstructured":"Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK (2018) VEST Investigators. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med 379(13):1205\u20131215. https:\/\/doi.org\/10.1056\/NEJMoa1800781","journal-title":"N Engl J Med"},{"issue":"5","key":"10638_CR13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/jce.15417","volume":"33","author":"JE Poole","year":"2022","unstructured":"Poole JE, Gleva MJ, Birgersdotter-Green U, Branch KRH, Doshi RN, Salam T, Crawford TC, Willcox ME, Sridhar AM, Mikdadi G, Beinart SC, Cha YM, Russo AM, Rowbotham RK, Sullivan J, Gustavson LM, Kivilaid K (2022) A wearable cardioverter defibrillator with a low false alarm rate. J Cardiovasc Electrophysiol 33(5):831\u2013842. https:\/\/doi.org\/10.1111\/jce.15417","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"10638_CR14","doi-asserted-by":"publisher","first-page":"euae189","DOI":"10.1093\/europace\/euae189","volume":"26","author":"M Chovanec","year":"2024","unstructured":"Chovanec M, Petr\u016f J, H\u00e1la P, Kralovec S, Thakkar AB, Mathews K, Dinger M, Ullery S, Eapen ZJ, Kumar UN, Neu\u017eil P (2024) First human safety and effectiveness study of defibrillation with a novel patch wearable cardioverter-defibrillator. Europace 26(7):euae189. https:\/\/doi.org\/10.1093\/europace\/euae189","journal-title":"Europace"},{"key":"10638_CR15","doi-asserted-by":"publisher","unstructured":"Migliore F, Perrotta L, Mills MT, Anic A, Sultan A, Futyma P, Mazurek M, Nesti M, Duray GZ, Pittorru R, Chun JKR (2025) Role of the wearable cardioverter defibrillator in the initial period of sudden cardiac death risk stratification: results of a European Heart Rhythm Association survey. Europace. ;27(7):euaf118. https:\/\/doi.org\/10.1093\/europace\/euaf118. Erratum in: Europace. 2025;27(7):euaf148. doi: 10.1093\/europace\/euaf148. PMID: 40591493; PMCID: PMC12212048","DOI":"10.1093\/europace\/euaf118"},{"issue":"43","key":"10638_CR16","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1093\/eurheartj\/ehaf668","volume":"46","author":"D Duncker","year":"2025","unstructured":"Duncker D, Marijon E, Metra M, Piot O, Fudim M, Siebert U, Frey N, Maier LS, Bauersachs J (2025) Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT study. Eur Heart J 46(43):4597\u20134606. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf668","journal-title":"Eur Heart J"},{"issue":"6","key":"10638_CR17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.33963\/v.phj.104890","volume":"83","author":"M Sterli\u0144ski","year":"2025","unstructured":"Sterli\u0144ski M, Przybylski A, Grabowski M, Kempa M, Ka\u017amierczak J, Mitkowski P, Ptaszy\u0144ski P, Sokal A, Baran J, Bissinger A, Dani\u0142owicz-Szymanowicz L, Dobrzycki S, Dzieli\u0144ska Z, Gierlotka M, Gil RJ, Farkowski MM, Chy\u017cy T, Kowalski O, Kryczka K, Olajossy B, Pawlak A, P\u0142onka J, \u015awier\u017cy\u0144ska-Wodarska E, Szumowski \u0141, Tajstra M, W\u0142odarczak A, Wieniawski P, Wojtaszczyk A, Wr\u00f3bel B, Wranicz JK (2025) Wearable cardioverter-defibrillator use in clinical settings in Poland: Nationwide observational cohort study. Kardiol Pol 83(6):741\u2013746. https:\/\/doi.org\/10.33963\/v.phj.104890","journal-title":"Kardiol Pol"},{"issue":"1","key":"10638_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/europace\/euaa268","volume":"23","author":"R Garcia","year":"2021","unstructured":"Garcia R, Combes N, Defaye P, Narayanan K, Guedon-Moreau L, Boveda S, Blangy H, Bouet J, Briand F, Chevalier P, Cottin Y, Da Costa A, Degand B, Deharo JC, Eschalier R, Extramiana F, Goralski M, Guy-Moyat B, Guyomar Y, Hermida JS, Jourda F, Lellouche N, Mahfoud M, Manenti V, Mansourati J, Martin A, Pasqui\u00e9 JL, Ritter P, Rollin A, Tibi T, Yalioua A, Gras D, Sadoul N, Piot O, Leclercq C, Marijon E (2021) Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study. Europace 23(1):73\u201381. https:\/\/doi.org\/10.1093\/europace\/euaa268","journal-title":"Europace"},{"issue":"17","key":"10638_CR19","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.115.015677","volume":"132","author":"V Kutyifa","year":"2015","unstructured":"Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I (2015) Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Circulation 132(17):1613\u20131619. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015677","journal-title":"Circulation"},{"issue":"2","key":"10638_CR20","doi-asserted-by":"publisher","first-page":"e003648","DOI":"10.1136\/openhrt-2025-003648","volume":"12","author":"A Matteucci","year":"2025","unstructured":"Matteucci A, Bonanni M, Sgarra L, Pignalberi C, Aquilani S, Di Fusco SA, Mariani MV, Pierucci N, Lavalle C, Fedele S, Nardi F, Colivicchi F (2025) Wearable cardioverter defibrillator for transient arrhythmic risk and sudden cardiac death prevention: a systematic review and updated meta-analysis. Open Heart 12(2):e003648. https:\/\/doi.org\/10.1136\/openhrt-2025-003648","journal-title":"Open Heart"},{"issue":"12","key":"10638_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1161\/CIRCULATIONAHA.122.061546","volume":"147","author":"N Bergh","year":"2023","unstructured":"Bergh N, Skoglund K, Fedchenko M, Bollano E, Eriksson P, Dellborg M, Wai Giang K, Mandalenakis Z (2023) Risk of heart failure in congenital heart disease: A nationwide register-based cohort study. Circulation 147(12):982\u2013984","journal-title":"Circulation"},{"issue":"14","key":"10638_CR22","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.jacc.2022.01.040","volume":"79","author":"AC Egbe","year":"2022","unstructured":"Egbe AC, Miranda WR, Pellikka PA, DeSimone CV, Connolly HM (2022) Prevalence and Prognostic Implications of Left Ventricular Systolic Dysfunction in Adults With Congenital Heart Disease. J Am Coll Cardiol 79(14):1356\u20131365. https:\/\/doi.org\/10.1016\/j.jacc.2022.01.040","journal-title":"J Am Coll Cardiol"},{"key":"10638_CR23","doi-asserted-by":"publisher","first-page":"131152","DOI":"10.1016\/j.ijcard.2023.131152","volume":"387","author":"K Andi","year":"2023","unstructured":"Andi K, Abozied O, Miranda WR, Anderson JH, Connolly HM, Jain CC, Burchill LJ, Egbe AC (2023) Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease. Int J Cardiol 387:131152. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131152","journal-title":"Int J Cardiol"},{"issue":"Suppl 1","key":"10638_CR24","doi-asserted-by":"publisher","first-page":"i42","DOI":"10.1093\/eurheartjsupp\/suaf092","volume":"28","author":"F Fusco","year":"2026","unstructured":"Fusco F, Di Salvo G, Nyktari E, Ladouceur M, Greutmann M, Jansen K, Russo MG, Scognamiglio G (2026) Recent advances in congenital heart disease with a systemic right ventricle: new insights for heart failure treatment from last EURO-ACHD Congress 2025. Eur Heart J Suppl 28(Suppl 1):i42\u2013i49. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suaf092","journal-title":"Eur Heart J Suppl"},{"issue":"24","key":"10638_CR25","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.3390\/jcm13247659","volume":"13","author":"GD Ciriello","year":"2024","unstructured":"Ciriello GD, Altobelli I, Fusco F, Colonna D, Correra A, Papaccioli G, Romeo E, Scognamiglio G, Sarubbi B (2024) Sacubitril\/Valsartan and Dapagliflozin in Patients with a Failing Systemic Right Ventricle: Effects on the Arrhythmic Burden. J Clin Med 13(24):7659. https:\/\/doi.org\/10.3390\/jcm13247659","journal-title":"J Clin Med"},{"issue":"21","key":"10638_CR26","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1136\/heartjnl-2020-318074","volume":"107","author":"TE Zandstra","year":"2021","unstructured":"Zandstra TE, Nederend M, Jongbloed MRM, Ki\u00e8s P, Vliegen HW, Bouma BJ, Tops LF, Schalij MJ, Egorova AD (2021) Sacubitril\/valsartan in the treatment of systemic right ventricular failure. Heart 107(21):1725\u20131730. https:\/\/doi.org\/10.1136\/heartjnl-2020-318074","journal-title":"Heart"},{"issue":"20","key":"10638_CR27","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1136\/heartjnl-2022-322332","volume":"109","author":"M Nederend","year":"2023","unstructured":"Nederend M, Ki\u00e8s P, Regeer MV, Vliegen HW, Mertens BJ, Robbers-Visser D, Bouma BJ, Tops LF, Schalij MJ, Jongbloed MRM, Egorova AD (2023) Tolerability and beneficial effects of sacubitril\/valsartan on systemic right ventricular failure. Heart 109(20):1525\u20131532. https:\/\/doi.org\/10.1136\/heartjnl-2022-322332","journal-title":"Heart"},{"issue":"2","key":"10638_CR28","doi-asserted-by":"publisher","first-page":"e009848","DOI":"10.1161\/CIRCHEARTFAILURE.122.009848","volume":"16","author":"F Fusco","year":"2023","unstructured":"Fusco F, Scognamiglio G, Merola A, Iannuzzi A, Palma M, Grimaldi N, Sarubbi B (2023) Safety and Efficacy of Sacubitril\/Valsartan in Patients With a Failing Systemic Right Ventricle: A Prospective Single-Center Study. Circ Heart Fail 16(2):e009848","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10638_CR29","doi-asserted-by":"publisher","first-page":"e040302","DOI":"10.1161\/JAHA.124.040302","volume":"14","author":"M Albertini","year":"2025","unstructured":"Albertini M, Waldmann V, David P, Barat A, Legendre A, Chaussade AS, Iserin L, Ladouceur M (2025) Safety and Efficacy of Dapagliflozin in Patients With Systemic Right Ventricular Dysfunction: DAPA-SRV Trial. J Am Heart Assoc 14(11):e040302. https:\/\/doi.org\/10.1161\/JAHA.124.040302","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10638_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.108.775221","volume":"119","author":"DM Harrild","year":"2009","unstructured":"Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F, Walsh EP (2009) Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation 119(3):445\u2013451. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.775221","journal-title":"Circulation"},{"issue":"10","key":"10638_CR31","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.jacep.2021.02.022","volume":"7","author":"F Bessi\u00e8re","year":"2021","unstructured":"Bessi\u00e8re F, Gardey K, Bouzeman A, Duthoit G, Koutbi L, Labombarda F, Marqui\u00e9 C, Gourraud JB, Mondoly P, Sellal JM, Bordachar P, Hermida A, Anselme F, Asselin A, Audinet C, Bernard Y, Boveda S, Chevalier P, Clerici G, da Costa A, de Guillebon M, Defaye P, Eschalier R, Garcia R, Guenancia C, Guy-Moyat B, Henaine R, Irles D, Iserin L, Jourda F, Ladouceur M, Lagrange P, Laredo M, Mansourati J, Massouli\u00e9 G, Mathiron A, Maury P, Nguyen C, Ninni S, Perier MC, Pierre B, Sacher F, Walton C, Winum P, Martins R, Pasqui\u00e9 JL, Thambo JB, Jouven X, Combes N, Di Filippo S, Marijon E, Waldmann V (2021) Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator. JACC Clin Electrophysiol 7(10):1285\u20131293. https:\/\/doi.org\/10.1016\/j.jacep.2021.02.022","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"10638_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ipej.2022.06.005","volume":"22","author":"B Sarubbi","year":"2022","unstructured":"Sarubbi B, Palma M, Merola A, Fusco F, Correra A, Colonna D, Romeo E, Grimaldi N, Ciriello GD, Scognamiglio G (2022) Russo MG Wearable cardioverter-defibrillator (life-vest): A feasible bridging treatment in adult congenital heart disease. Indian Pacing Electrophysiol J 22(5):217\u2013222.","journal-title":"Indian Pacing Electrophysiol J"},{"issue":"6","key":"10638_CR33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/chd.12833","volume":"14","author":"B Zielonka","year":"2019","unstructured":"Zielonka B, Kim YY, Supple GE, Partington SL, Ruckdeschel ES, Marchlinski FE, Frankel DS (2019) Improvement in ventricular function with rhythm control of atrial arrhythmias may delay the need for atrioventricular valve surgery in adults with congenital heart disease. Congenit Heart Dis 14(6):931\u2013938. https:\/\/doi.org\/10.1111\/chd.12833 Epub 2019 Aug 5. PMID: 31385437","journal-title":"Congenit Heart Dis"},{"issue":"1","key":"10638_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1161\/CIRCEP.114.001929","volume":"8","author":"GF Kapel","year":"2015","unstructured":"Kapel GF, Reichlin T, Wijnmaalen AP, Piers SR, Holman ER, Tedrow UB, Schalij MJ, Stevenson WG, Zeppenfeld K (2015) Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease. Circ Arrhythm Electrophysiol 8(1):102\u2013109. https:\/\/doi.org\/10.1161\/CIRCEP.114.001929 Epub 2014 Nov 24. PMID: 25422392","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10638_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/heartjnl-2020-316791","volume":"107","author":"JM Oliver","year":"2021","unstructured":"Oliver JM, Gallego P, Gonzalez AE, Avila P, Alonso A, Garcia-Hamilton D, Peinado R, Dos-Subir\u00e0 L, Pijuan-Domenech A, Rueda J, Rodriguez-Puras MJ, Garcia-Orta R, Mart\u00ednez-Quintana E, Datino T, Fernandez-Aviles F, Bermejo J, Spanish ACHD (2021) Network. Predicting sudden cardiac death in adults with congenital heart disease. Heart 107(1):67\u201375. https:\/\/doi.org\/10.1136\/heartjnl-2020-316791 Epub 2020 Jun 16. PMID: 32546506","journal-title":"Heart"},{"issue":"1","key":"10638_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jacep.2016.07.010","volume":"3","author":"K Vakil","year":"2017","unstructured":"Vakil K, Duval S, Cogswell R, Eckman P, Levy WC, Anand I, Dardas T, Adabag S (2017) Impact of Implantable Cardioverter-Defibrillators on Waitlist Mortality Among Patients Awaiting Heart Transplantation: An UNOS\/OPTN Analysis. JACC Clin Electrophysiol 3(1):33\u201340 Epub 2016 Sep 14. PMID: 29759692","journal-title":"JACC Clin Electrophysiol"},{"issue":"6Part B","key":"10638_CR37","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.hroo.2021.09.013","volume":"2","author":"AY Lin","year":"2021","unstructured":"Lin AY, Duran JM, Sykes A, Darden D, Urey M, Hsu JC, Adler ED, Birgersdotter-Green U (2021) Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review. Heart Rhythm O2 2(6Part B):710\u2013718 PMID: 34988520; PMCID: PMC8710633","journal-title":"Heart Rhythm O2"},{"issue":"10","key":"10638_CR38","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.healun.2024.05.010","volume":"43","author":"Y Peled","year":"2024","unstructured":"Peled Y, Ducharme A, Kittleson M, Bansal N, Stehlik J, Amdani S, Saeed D, Cheng R, Clarke B, Dobbels F, Farr M, Lindenfeld J, Nikolaidis L, Patel J, Acharya D, Albert D, Aslam S, Bertolotti A, Chan M, Chih S, Colvin M, Crespo-Leiro M, D\u2019Alessandro D, Daly K, Diez-Lopez C, Dipchand A, Ensminger S, Everitt M, Fardman A, Farrero M, Feldman D, Gjelaj C, Goodwin M, Harrison K, Hsich E, Joyce E, Kato T, Kim D, Luong ML, Lyster H, Masetti M, Matos LN, Nilsson J, Noly PE, Rao V, Rolid K, Schlendorf K, Schweiger M, Spinner J, Townsend M, Tremblay-Gravel M, Urschel S, Vachiery JL, Velleca A, Waldman G, Walsh J (2024) International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024. J Heart Lung Transpl 43(10):1529\u20131628e54. https:\/\/doi.org\/10.1016\/j.healun.2024.05.010 Epub 2024 Aug 8. PMID: 39115488","journal-title":"J Heart Lung Transpl"},{"issue":"10","key":"10638_CR39","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.healun.2015.04.004","volume":"34","author":"M Opreanu","year":"2015","unstructured":"Opreanu M, Wan C, Singh V, Salehi N, Ahmad J, Szymkiewicz SJ, Thakur RK (2015) Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis. J Heart Lung Transpl 34(10):1305\u20131309 Epub 2015 May 4. PMID: 26094085","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"10638_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/europace\/euaa268","volume":"23","author":"R Garcia","year":"2021","unstructured":"Garcia R, Combes N, Defaye P, Narayanan K, Guedon-Moreau L, Boveda S, Blangy H, Bouet J, Briand F, Chevalier P, Cottin Y, Da Costa A, Degand B, Deharo JC, Eschalier R, Extramiana F, Goralski M, Guy-Moyat B, Guyomar Y, Hermida JS, Jourda F, Lellouche N, Mahfoud M, Manenti V, Mansourati J, Martin A, Pasqui\u00e9 JL, Ritter P, Rollin A, Tibi T, Yalioua A, Gras D, Sadoul N, Piot O, Leclercq C, Marijon E (2021) Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study. Europace 23(1):73\u201381. https:\/\/doi.org\/10.1093\/europace\/euaa268","journal-title":"Europace"},{"key":"10638_CR41","doi-asserted-by":"publisher","unstructured":"Carvajal V, Reyes FB, Gonzalez D, Schwartz M, Whitlow A, Alegria JR (2024) Endocarditis in Adult Congenital Heart Disease Patients: Prevention, Recognition, and Management. Curr Cardiol Rep. ;26(9):1031\u20131045. https:\/\/doi.org\/10.1007\/s11886-024-02103-9. Epub 2024 Aug 30. Erratum in: Curr Cardiol Rep. 2025;27(1):116. doi: 10.1007\/s11886-025-02268-x. PMID: 39212775; PMCID: PMC11379749","DOI":"10.1007\/s11886-024-02103-9"},{"issue":"26","key":"10638_CR42","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/eurheartj\/ehw591","volume":"38","author":"JM Kuijpers","year":"2017","unstructured":"Kuijpers JM, Koolbergen DR, Groenink M, Peels KCH, Reichert CLA, Post MC, Bosker HA, Wajon EMCJ, Zwinderman AH, Mulder BJM, Bouma BJ (2017) Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J 38(26):2048\u20132056. https:\/\/doi.org\/10.1093\/eurheartj\/ehw591","journal-title":"Eur Heart J"},{"issue":"3","key":"10638_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jacep.2016.09.002","volume":"3","author":"KA Ellenbogen","year":"2017","unstructured":"Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ (2017) Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry. JACC Clin Electrophysiol 3(3):243\u2013250 Epub 2016 Nov 23. PMID: 29759518","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"10638_CR44","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.amjcard.2011.07.021","volume":"108","author":"M Rao","year":"2011","unstructured":"Rao M, Goldenberg I, Moss AJ, Klein H, Huang DT, Bianco NR, Szymkiewicz SJ, Zareba W, Brenyo A, Buber J, Barsheshet A (2011) Wearable defibrillator in congenital structural heart disease and inherited arrhythmias. Am J Cardiol 108(11):1632\u20131638. https:\/\/doi.org\/10.1016\/j.amjcard.2011.07.021","journal-title":"Am J Cardiol"},{"issue":"1","key":"10638_CR45","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/eurheartjsupp\/suaf091","volume":"28","author":"B Sarubbi","year":"2026","unstructured":"Sarubbi B, Scognamiglio G (2026) Who will be our adult congenital heart disease patient tomorrow? Eur Heart J Suppl 28(1):i1\u2013i6. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suaf091","journal-title":"Eur Heart J Suppl"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10638-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10638-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10638-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:26:53Z","timestamp":1779690413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10638-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10638"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10638-y","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate."}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":".","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Web-site"}}],"article-number":"66"}}